CONFERENCE CHAIRS

PROFESSOR PAUL DIMITRI

PROFESSOR OF CHILD HEALTH & DIRECTOR OF TECHNOLOGY & INNOVATION, NIHR CHILDREN & YOUNG PEOPLE MEDTECH CO-OPERATIVE

Professor Paul Dimitri BSc, MBChB, FRCPCH, PhD

Professor Paul Dimitri is the National Institute for Health and Care Research (NIHR) National Children’s Specialty Lead, UK, the Director of the NIHR Children & Young People MedTech Co-operative (www.cypmedtech.nihr.ac.uk ), and the Clinical Director for the National Technology Innovation Transforming Child Health (TITCH) Network (www.titch.org.uk ). He has previously held national positions on UK national committees at the Royal College of Paediatrics and Child Health (RCPCH), and the Academy of the Medical Royal Colleges, and is the current Vice President for Science and Research at the RCPCH.

Paul is leading on the development of the National Centre for Child Health Technology, a global first bringing together industry, universities, healthcare professionals, children and young people and their families to develop the most advanced healthcare technologies for children worldwide. Paul has led on the development and implementation of national technology networks that specifically focus on the development and deployment of technology for paediatrics and child health through private and public sector collaboration. Paul currently works at Sheffield Children’s NHS Foundation Trust UK, as a Professor of Child Health, Consultant in Paediatric Endocrinology and Director of Technology & Innovation.

DAVID COLE, MBA

CO-FOUNDER / DIRECTOR, THINKING OF OSCAR & TOO FUTURES

David is an experienced technologist, senior leader, advisor, mentor, and social-impact entrepreneur, with a passion for innovation in healthcare specialising in children’s health.  David is a strategic advisor to several children’s hospitals including Alder Hey and Sheffield Children’s, where he focuses on commercial growth and sustainability.  David was recently awarded his MBA from the Open University with distinction, which included a research paper on the environment and resources required to advance children’s health outcomes through a culture of innovation, that delivers impact and sustainability; whilst understanding whether innovation within children’s services should differ to that of general health services. 

Previously, David had a distinguished career with IBM spanning over 24 years and has experience working across the UK, Europe, Australia, and the US.  Most recently he was a senior leader within IBM’s healthcare consulting division, and before that as the EMEA Leader for Watson Health.

David is the co-founder of children’s charity, Thinking of Oscar, which funds technology and innovation within paediatrics, whose mission is ‘to bring the future of healthcare to children’.  He hosts the Not Mini Adults Podcast – “Pioneers for Children’s Healthcare and Wellbeing”.  

David is a start-up mentor and is currently chairing a children’s health impact accelerator on behalf of Innovate UK.  He was recently appointed onto the digital health committee of the Royal College of Paediatrics and Child Health and is a mentor and advisor at the University of Oxford’s Saïd Business School.

PROFESSOR WENDY TINDALE, OBE

SCIENTIFIC DIRECTOR, SHEFFIELD TEACHING HOSPITALS

Professor Wendy Tindale is Scientific & Innovation Director at Sheffield Teaching Hospitals, UK. She holds a Chair at the University of Sheffield and is Director of the National Institute for Health Research ‘Devices for Dignity’ MedTech Co-operative – a catalyst for development of innovative medical devices and healthcare technologies. She has a passion for combining clinical excellence with business opportunities through commercial translation of innovative technologies and has worked with public and private sectors to facilitate collaborations. 

Wendy has advised the National Institute for Health and Care Excellence and multiple funding bodies on strategy, medtech funding and adoption. 

She holds a Beacon Award for outstanding contribution to healthcare and an Inspirational Women award for outstanding leadership. She received an OBE for Services to Healthcare in 2014 and was England’s Healthcare Scientist of the Year in 2016, receiving a lifetime achievement award in 2022. 

Within the NHS, Wendy leads a large Clinical Directorate supporting scientific services and innovative practices spanning imaging, clinical engineering and medical physics.

KEYNOTE SPEAKERS

DR ANNA MOORE

ASSISTANT PROFESSOR, CHILD PSYCHIATRY AND MEDICAL INFORMATICS, UNIVERSITY OF CAMBRIDGE

CHT2023 Talk: Towards personalised preventative pathways for children’s mental health

Anna is working towards building personalised preventative pathways for child mental health. She is doing this through close working with the public and developing diverse multi-agency partnerships. Through these she is developing novel informatics infrastructure for research and clinical practice, enabling clinical genetics in child psychiatry to become routine practice and developing digital AI tools to support early, personalised care. To support this, she is leading the NIHR Bio Resource’s D-CYPHR programme, the largest ever program to involve children in genetics research (https://bioresource.nihr.ac.uk/dcyphr/).

NICKY RUNECKLES

DIGITAL HEALTH CONSULTANT, MONTICOLA

CHT2023 Talk: Improving the mental health of children and young people – HealthTech’s impact, barriers and opportunities

Nicky has worked in digital mental health since 2011. Her background is in traditional mental health and substance misuse services, where she held senior operational and business development roles. Then as Commercial Director of the ground-breaking digital mental health service, Big White Wall, for four years, she was instrumental in expanding its impact in the UK. Since then, she’s worked with providers, commissioners, NHS, private and charities to expand the impact of innovation for the benefit of children, young people and families.

PROFESSOR MICHAEL CORK

CONSULTANT DERMATOLOGIST AND HEAD OF SHEFFIELD DERMATOLOGY RESEARCH, SHEFFIELD CHILDREN’S HOSPITAL AND THE UNIVERSITY OF SHEFFIELD

CHT2023 Talk: Paediatric Atopic Dermatitis

Professor Michael J. Cork is head of Sheffield Dermatology Research; in the Dept. of Infection, Immunity & Cardiovascular Disease; Faculty of Medicine, Dentistry & Health; at The University of Sheffield, UK. He is a Consultant Dermatologist to Sheffield Children’s Hospital (SCH) NHS Trust and to Sheffield Teaching Hospitals (STH) NHS Trust.

He specialises in treating children and adults with the most severe atopic dermatitis and sees patients from anywhere in the UK. At Sheffield Children’s Hospital he leads an integrated atopic dermatitis – allergy – psychiatry clinic, designed to manage the most complex patients. He leads clinical trials of new treatments for atopic dermatitis at the Clinical Research Facilities at SCH for children and at STH for adults. He is Chief Investigator in the UK for many of the trials for new biologics, small molecules and topicals for atopic dermatitis.

With Dr. Simon Danby, they have created a dedicated clinical research facility for skin barrier, biomarker research. Their Sheffield Dermatology Research Team have developed a research facility that has developed a unique combination of techniques to assess how topical wash products, emollients and topical/systemic pharmaceutical agents affect the integrity of the skin barrier and inflammation in normal and AD skin. These biomarkers are used to assess the safety and efficacy of treatments for atopic dermatitis. These atopic dermatitis biomarkers are also being used in experimental medicine clinical trials to stratify patients according to clinical response and safety parameters. This information can be used to determine how long a treatment should be used for, the optimum dose, the effect on some comorbidities and inform health economic evaluations. Please see link to our new website https://sheffielddermatologyresearch.com/

Our research group also has a special interest in the prevention of atopic dermatitis. This involves both mechanistic studies and large collaborative clinical trials. We investigate how the environment of a baby interacts with their skin to induce the development of atopic dermatitis. A major focus is on how topical wash products, emollients, oils and water itself, affect the skin barrier and how this leads to the development of atopic dermatitis. This is leading to the design of combinations of topical products, which have the optimum effect on the development and maintenance of the skin barrier.

DR SANDRA LJ JOHNSON

DEVELOPMENTAL PAEDIATRICIAN AND CLINICAL ACADEMIC, UNIVERSITY OF SYDNEY FACULTY OF MEDICINE AND HEALTH SCIENCE

CHT2023 Talk: AI technology into the future: what is our role as paediatricians?

Sandra L J Johnson is paediatrician in child development and clinical academic in the Faculty of Medicine & Health Sciences at the University of Sydney. She is Fellow of the Royal Society of Medicine UK, Fellow of Royal College of Paediatrics and Child Health UK (RCPCH), Fellow of Royal Australasian College of Physicians (RACP), Fellow of Australasian College of Legal Medicine (ACLM) and Honorary Fellow of American College of Legal Medicine (CLM). She was the President of the Australasian College of Legal Medicine in 2018 and 2019.

Sandra is the main author of the textbook: “A clinical handbook on child development paediatrics” published by Elsevier in 2012 and she self-published a book in 2013 for parents: “Your child’s development.”

Sandra represented the RACP for the Australian National Children’s Digital Health Collaborative work on eHealth records, she is member of the RACP Digital Health Advisory Group, and she is the RACP representative to the Australian Institute of Digital Health for the Clinical Informatics Fellowship Program.

Her personal research in AI technology spans 8 years. She did a keynote address at the American College of Legal Medicine conference in February 2019 on “AI, Machine Learning and Ethics in Healthcare” and she has a published article on this topic in Journal of Legal Medicine (JLM). In January 2023 her article on “AI in Healthcare: the challenge of Regulation” was published in JLM. She has many peer reviewed published articles that can be viewed at https://orcid.org/0000-0001-5583-908X

Sandra has focussed on AI in Healthcare with respect to ethics, regulation and governance. She is passionate about sharing what she has learned. She believes that the education of doctors and health professionals in the field of AI into the future is essential in view of the rapid expansion of this technology and its increasing importance in Medicine.

DR JAMES WALL

DIRECTOR, UCSF-STANFORD PAEDIATRIC DEVICE CONSORTIUM

CHT2023 Talk: Pediatric Health Technology Innovation – Lessons from US

James Wall is an Associate Professor of Pediatric Surgery at Stanford University who specializes in minimally-invasive approaches to children’s surgery. He is a physician entrepreneur who has developed multiple health technologies from idea to commercialization.  James is currently a Director of the Stanford Biodesign Innovation and Policy Fellowships as well as co-director of the UCSF-Stanford Pediatric Device Consortium. The programs that he leads at Stanford are responsible for the development of health technologies that benefit patients globally. James is passionate about building sustainable businesses that address the needs of the underserved patients in the pediatric, maternal and fetal populations.

DR DAMIEN YEO

CONSULTANT PAEDIATRIC OPTHALMOLOGIST, ALDER HEY CHILDREN’S NHS FOUNDATION TRUST

CHT2023 Talk: Driving remote digital care transformation in paediatric ophthalmology

Damien Yeo is a Consultant Ophthalmologist at Alder Hey Children’s Hospital where he specialises in paediatric eye conditions.

After his residency, Damien completed further fellowships in Great Ormond Street Hospital, Moorfields Eye Hospital, and the Royal London Hospital before taking up his consultant post in Liverpool. He has multiple publications in journals and has written a few book chapters. His research interests include topics on visual development, digital health, strabismus, and ophthalmic genetics. He has presented his research at the international level and has been an invited speaker at the Royal Society of Medicine. He is a NHS Clinical Entrepreneur interested in developing technology that has a direct impact on children’s eye health.

He believes that the traditional model of healthcare will not keep up with the burgeoning needs of the population and that change is required in both primary and secondary care. Damien is a keen adopter of new technology and ideas. He is passionate about a sustainable future, which he strongly believes will involve artificial intelligence, digital solutions, personalised medicine and the up-skilling of all allied health professionals.

SEMINAR SPEAKERS

DOMINIC RABAN

CEO, XPLORO

CHT2023 Talk: Using augmented reality and gamification to reduce anxiety for young patients

Dom Raban is the co-founder and CEO of Xploro, a patient engagement platform that uses augmented reality, artificial intelligence and games to reduce anxiety for young patients. Dom established Xploro after his daughter had recovered from cancer treatment. He realised that the lack of information she received about treatments, people and places increased her anxiety and has affected her long-term engagement with health services. This led him to the conclusion that age-appropriate information can be a bona fide clinical therapy. Now the award-winning platform is in use in hospitals in the UK, USA, Europe and Africa with global headquarters in Cleveland, Ohio. Dom has been creating ‘stuff’ for over 40 years, from punk fanzines in the 1970s to content for emerging technology platforms now. He’s been in the digital space since the start, building his first website in 1995 and his first 3D virtual environment in 1996. He is also Chair of Corporation Pop, a digital innovation agency that specialises in a user-centred design approach to develop apps, games and software.

DR STEFAN AGAMANOLIS

CHIEF STRATEGY OFFICER, XPLORO

CHT2023 Talk: Live Q&A for Xploro seminar

Stefan is Chief Strategy Officer for Xploro.  He heads up Xploro’s US operations and plays a lead role in company and product development strategy.  He holds a PhD from the Massachusetts Institute of Technology and spent over a decade at Akron Children’s Hospital in Ohio as Director of Patient Experience then, latterly, as Chief Innovation Officer. He also holds parallel strategy and consultancy roles in medtech, research and entrepreneurship.

DR NEVILLE YOUNG

DIRECTOR OF ENTERPRISE AND INNOVATION, HEALTH INNOVATION YORKSHIRE AND HUMBER

CHT2023 Talk: Fuelling a thriving health ecosystem for health and economic growth

Dr Neville Young joined the Yorkshire & Humber Academic Health Science Network in June 2016. He has a real interest and track record in supporting the delivery of high-quality research and innovation in the United Kingdom. Neville is an NIHR reviewer and sits on the AAC rapid uptake product industry liaison group.

Dr Young has worked as an academic researcher, a drug trial manager, a consultant, as a director for a health tech start up and is focused on helping to identify and support the “pull” from the healthcare systems for innovative health technologies.

He completed his doctorate in Molecular Embryology from Kings College London, before working at the Institute of Cancer Research in London and then the Institute of Molecular Bio-Sciences in Queensland, Australia before returning to the UK and working in research development, Healthtech innovation and the AHSN network.

KATHY SCOTT

DEPUTY CEO, HEALTH INNOVATION YORKSHIRE AND HUMBER

CHT2023 Talk: Innovating to reach Net Zero

Kathy is Deputy Chief Executive for  Health Innovation Yorkshire and Humber (previously the Y&H Academic Health Science Network) supporting the spread of innovation across the region and leads on Environmental Sustainability and Healthcare Innovation for the AHSN.  Prior to joining the AHSN she was Head of Innovation and Research in NHS England and a career civil servant, working in several Departments across a variety of roles.

Kathy holds an MA in Public Service Management from the University of York, an MSc in Health Policy from Imperial College London and is a trained mediator, graduate assessor, mentor, action learning set facilitator and coach.

DR DIANA FERRO

PHD RESEARCH AND DATA SCIENTIST, BAMBINO GESÙ CHILDREN’S HOSPITAL

CHT2023 Talk: AI innovation opportunities for children

Sponsored by Merck

Diana Ferro, Ph.D., is a Researcher and Data Scientist at the Predictive & Preventive Medicine Research Unit at Ospedale Pediatrico Bambino Gesù (OPBG) in Rome. She was among the inaugural group of healthcare professionals certified by the American Board for AI in Medicine. Before her current position, Dr. Ferro was a Research Assistant Professor of Pediatrics at the University of Missouri-Kansas City, USA. She pioneered a data infrastructure employing AI algorithms for “all-hand data” at the point-of-care in the Diabetes Clinics of Children’s Mercy Hospital. This system harnesses real-time data to predict complications for children with chronic illnesses. Additionally, she utilized Real-World Data to study COVID-19-related hospitalizations, particularly focusing on cardiac complications. Presently, Dr. Ferro is conducting clinical research within the European Health Data Space framework at OPBG. Her endeavors include advocating for the adoption of Common Data Standards and developing Digital Twins — virtual representations of a patient’s care journey. These digital representations of the patient’s care journey enable healthcare professionals to test and refine treatment approaches in a virtual environment before implementing them in real-world situations. With the power of AI in medicine, Dr. Ferro aims to revolutionize pediatric care, making treatments more personalized, efficient, and effective. Her vision is to pave the way for a new era of healthcare, where data-driven insights inform clinical decisions, ultimately enhancing the quality of life for pediatric patients worldwide.

DR ANTONIO DE ARRIBA MUÑOZ

PAEDIATRIC ENDOCRINOLOGIST, MIGUEL SERVET HOSPITAL

CHT2023 Talk: Case Studies of Growth Hormone Deficiency in Children

Sponsored by Merck

Paediatric endocrinology with special interest in new technologies and mobile apps to improve the assistance of our patients.

DR CLARE LANKESTER

REGULATORY EXPERT IN RESIDENCE, THE UNIVERSITY OF SHEFFIELD

CHT2023 Talk: An overview of regulatory requirements for medical technologies

Dr Clare Lankester is a Visiting Academic at The University of Sheffield where she supports academics and professional staff to understand relevant regulatory frameworks and how they apply to medical technology projects. Away from TUoS, Clare has a number of other roles across the MedTech landscape, primarily relating to the development and clinical testing of novel medical devices.

EMMA GLASS

UNIVERSITY PARTNERSHIPS MANAGER FOR HEALTHCARE TECHNOLOGIES, BRITISH STANDARDS INSTITUTE

CHT2023 Talk: An overview of regulatory requirements for medical technologies

Emma Glass is the University Partnerships Manager for Healthcare Technologies in the Knowledge Solutions division of the British Standards Institute (BSI). She is responsible for engaging with universities in healthcare technology research and innovation to promote participation and raise awareness of standards and standards development. Recent work has included hosting an interactive workshop for MSc students on the value of standards in healthcare and collaborating with universities on innovative research projects in the sector. Prior to working at BSI, Emma launched new open-access science journals in digital health, nuclear medicine and radiology. She also authored CBP’s Big Data Focus Report in 2016 and 2017. Emma has a degree in English Literature from the University of Exeter.

LIZ ASHALL-PAYNE

FOUNDING CEO, ORCHA HEALTH

CHT2023 Talk: Empowering children and young people with the potential of digital health

 Liz Ashall-Payne is the Founding CEO of ORCHA, a global leader in digital health accreditation and distribution services. With a background as a trained NHS Clinician, Liz has led healthcare transformation programs, unlocking the potential of digital technology for improved patient outcomes and economic opportunities.

In 2015, Liz established ORCHA, attracting investments from influential figures such as Sir Terry Leahy and Bill Currie. The organization has experienced exponential growth, providing digital health assessment and distribution services in twelve countries and serving organizations in 70% of NHS regions in the UK.

Under Liz’s leadership, ORCHA has been the recipient of numerous awards, cementing its position as an industry leader. Liz herself has been recognized as a Tech Trailblazer by the BIMA 100, a Healthcare IT Leader in the HIMSS Future 50, and Entrepreneur of the Year by esteemed organizations including the British Chamber of Commerce, Norther Powerhouse, and EY. Her outstanding contributions have also been acknowledged through her inclusion in the LDC top 50 list.

In addition to her role at ORCHA, Liz Ashall-Payne is an NHS England NIA alumni fellow, a coach for the NHS England Clinical Entrepreneur program, and serves as the Vice Chair on the Tech UK Health and Social Care Council.

DR TIMOTHY CHOU

FOUNDER, BEVELCLOUD

CHT2023 Talk: Pediatric Moonshot

After completing his PhD, Dr. Chou came to work at one of the original Silicon Valley startups, Tandem Computers. In parallel he also started teaching computer architecture at Stanford University. In 1999 he went to Oracle to become the first President of Oracle’s cloud computing business. He authored the landmark book, The End of Software, which in 2004 predicted the rise of software-as-service. After retiring from Oracle, he returned to Stanford to start the first class on cloud computing in 2015.  Now in its 15th year the course (cs309a.stanford.edu) has featured guest lectures by over 100 public company CEOs.  A few years ago one of the students introduced him to the world of pediatric medicine and inspired him to come out of retirement to work on his last great project – the Pediatric Moonshot.

PROFESSOR JIM WILD

PROFESSOR OF MAGNETIC RESONANCE PHYSICS, INSIGNEO INSTITUTE, UNIVERSITY OF SHEFFIELD

CHT2023 Talk: Insigneo

Digital Health Hub panel discussion

Jim Wild is an MRI physicist who has developed and translated new ways to image the lungs with hyperpolarised MRI. He is also the Director of the Insigneo Institute in Sheffield that drives innovative research at the interface of healthcare, engineering and science to transform the future of healthcare technology.

PROFESSOR TIM CHICO

DIRECTOR, SOUTH YORKSHIRE DIGITAL HEALTH HUB

CHT2023 Talk: The South Yorkshire Digital Health Hub

Digital Health Hub panel discussion

Tim is Professor of Cardiovascular Medicine at the University of Sheffield and a consultant Cardiologist at Sheffield Teaching Hospitals NHS Foundation Trust. His national roles include Associate Director of the British Heart Foundation Data Science Centre, where he leads the Smartphone and Wearable data theme.

Tim’s career has spanned academia and industry across genetics, vascular biology, drug discovery and health data science. He jointly leads South Yorkshire’s specialist service for pregnant women with heart disease and sits on the council of the UK Maternal Cardiology Society.

DR JAMES TAYLOR

CLINICAL RESEARCH SCIENTIST, GOOGLE

CHT2023 Talk: Technology to transform paediatric healthcare

Digital Health Hub panel discussion

For college and medical school, Dr. Taylor  attended the University of North Carolina at Chapel Hill, graduating from medical school in 1980.  He completed a pediatric residency at the University of Colorado Denver, and after a four-year stint in private  practice,  completed a fellowship in General Pediatrics at the University of Washington.  Dr. Taylor was on the faculty at University of Washington  from 1991-2019, and now holds the title of Professor emeritus.  His career as an academic pediatrician was balanced between teaching/patient care, administrative duties for the pediatric residency program and research.  His research interests included SIDS, vaccine delivery, management of URIs, and diagnosis of neonatal jaundice.  Dr. Taylor started a regional practice- based research network and co-founded the Better Outcomes through Research for Newborns (BORN) network, a national research network devoted to improving care for healthy neonates.  While at the University of Washington, he invented an app that measured newborn bilirubin levels and co-founded a small start-up to develop this technology.  In 2017, the company was acquired by Google and he has worked there since the acquisition as a clinical research scientist.  In this role, Dr. Taylor helps product teams design and conduct clinical research and analyze the results.  He also advises teams on the clinical utility of new or proposed products and services.

ANNE MARIE DAVIES

INNOVATION & INEQUALITIES PROGRAMME MANAGER, ALDER HEY CHILDREN’S HOSPITAL AND CHILDREN’S HOSPITAL ALLIANCE

CHT2023 Talk: Using predictive analytics to improve access to healthcare and optimise elective activity

Anne Marie Davies, Innovation and Inequalities Senior Programme Manager for the Children’s Hospital Alliance.  She is also an Associate Non-executive Director role at Liverpool Heart and Chest. Anne Marie Davies is responsible for the delivery, implementation and engagement of Innovation & Inequalities programme management activities across 13 membership trusts and voting member of the Cheshire & Merseyside ICB People Board.

Anne Marie is an accomplished programme leader with extensive experience in leading and efficiently managing large-scale business transformation initiatives working across multiple organisations underpinned by research and innovation.  Known for delivering complex programmes of work to achieve the strategic objectives for organisations ensuring the delivery of operational efficiencies and service user and staff experience. 

Anne Marie joined the NHS in 2012 gaining significant experience in complex transformation; strategic acquisitions/mergers and working across organisational boundaries.  Prior to this, she worked in a Local Authority in neighbourhood management leading Community Engagement projects.  She has a deep understanding of public sector goals, culture, and processes and strong leadership and communication skills having worked in both the NHS and Local Authority.

DR JACINTA CORDWELL

CONSULTANT CLINICAL PSYCHOLOGIST, CHILD HEALTH INNOVATIONS

CHT2023 Talk: Nell and the Neonatal Unit: An innovation to support neonatal siblings

Dr Jacinta Cordwell is a Consultant Clinical Psychologist working for the Thames Valley

and Wessex Neonatal ODN, is Lead for Neonatal Psychology at the John Radcliffe Hospital in Oxford and works with children and families in private practice. 

Jacinta is passionate about early intervention for infants and families within the perinatal period, particularly in supporting families with mental health, adjustment

to difficult situations and supporting positive parent-infant/child relationships. She has significant experience in working with psychological trauma and is particularly interested in how we develop more trauma and psychologically informed environments across neonatal services.

DR RIA EVANS FRY

NEONATAL SUB SPECIALTY TRAINEE, CHILD HEALTH INNOVATIONS

CHT2023 Talk: Nell and the Neonatal Unit: An innovation to support neonatal siblings

Dr Ria Evans Fry is a senior Neonatal registrar working at Birmingham Women’s & Children’s NHS Trust. Ria is also a mother of two daughters, the youngest of whom was born at 28 weeks gestation and spent 10 weeks in a Neonatal Unit.

Ria’s work has been greatly influenced by being a parent on a neonatal unit. The experience has fostered a passion for family integrated and developmental care, compassion within neonatal services and learning from those with lived experiences of healthcare.

Ria is interested in how holistic care of neonatal families might improve both short and longer term outcomes for the most vulnerable babies whilst reducing the burden on the mental health of their parents and siblings.

Ria’s other interests lie in Neonatal transport, pain management and palliative care, and teaching.

PROFESSOR SIMEON YATES

PROFESSOR OF DIGITAL CULTURE COMMUNICATION AND MEDIA, UNIVERSITY OF LIVERPOOL

CHT2023 Talk: Digital exclusion: Minimum digital living standards and household wellbeing

Simeon is a Professor of Digital Culture in the Department of Communications and Media at the University of Liverpool and Joint Director of the Digital Media and Society Institute. He has undertaken research on the social, political and cultural impacts of digital media for over three decades. His work has a major focus on projects that address digital inclusion and exclusion issues, working with academic and government colleagues to develop policies and interventions to support digital inclusion. This includes working with the UK’s Department of Culture, Media and Sport (DCMS), the Department for Science, Innovation and Technology (DSIT), the UK’s media regulator Ofcom, and the Welsh Government. He also works extensively with charity organisations such as the Good Things Foundation, Cwmpas in Wales and SCVO in Scotland. In 2017 he was seconded to DCMS to act as research lead for the Digital Culture team – helping to develop the first UK “Digital Culture” policy. He is a member of the Greater Manchester City Region Mayoral Digital Inclusion Action Network and I am an appointed expert advisor to DCMS/DSIT and Ofcom.

SPOTLIGHT SEMINAR SPEAKERS

JOEL DE OLIVEIRA JR

FOUNDER, LUCKIE TECH

CHT2023 Talk: Technology without purpose is empty

Mechanical Engineer, MBA, abroad experience with more than 5 years living in Sweden, also France, Italy, Caribbean; experienced in Multinational Companies such as Ericsson, Embraer and Kaelus – After losing a son to cancer he drops his corporate career to launch Luckie Tech, that is a startup with a great goal, that is to reduce the mortality rate of children undergoing cancer treatment using high technology.

TECH DEMO SPEAKERS

UZAY MACAR

COFOUNDER & CTO, HIBI HEALTH LTD

CHT2023 Talk: Hibi: Smart care management tools and AI-driven personalised guidance

Uzay is a HealthTech entrepreneur, researcher, and engineer, currently based in London. He is the co-founder and CTO of Hibi, a digital care coordination platform for families caring for children with additional needs and long-term conditions. Having been involved in a multitude of commercial and research projects at the intersection of technology and healthcare across the US, Canada, and UK, he brings technical expertise in software and product development. Uzay is also co-leading a non-profit on artificial intelligence education for secondary school students, Aiphabet. Before that, he founded Nodr, next-generation task management software for healthcare professionals. He was a machine learning researcher at Montreal Institute of Learning Algorithms (Mila) and holds a Bachelor of Science degree in computer science and applied mathematics from Columbia University.

SAM MILLIKEN-SMITH

COFOUNDER & CEO, HIBI HEALTH LTD

CHT2023 Talk: Live Q&A for Hibi Tech Demo

I co-founded Hibi to provide support to those families caring for children with additional needs. We offer a digital platform that, for the first time, provides families with the tools, resources and support they need to coordinate care.

My career prior has focused on improving healthcare systems. Through my roles at Optum Ventures and The PSC, I’m fortunate to have worked with two of the world’s largest and most influential healthcare organisations – the NHS and UnitedHealth Group.

DR JAISHREE NAIDOO

CEO, ENVISIONIT DEEP AI LTD

CHT2023 Talk: Envisionit Deep AI, A holistic approach to AI

Dr Jaishree Naidoo is a paediatric radiologist with more than 22 years experience. She is the CEO and co-founder of Envisionit Deep AI, a medical technology company that utilizes a holistic approach to Artificial Intelligence to improve medical imaging diagnosis.

Her special area of interest in pattern recognition and deep learning in radiology is driven by her passion for her sub-speciality and the need to positively influence the lives of children by offering sustainable healthcare solutions. Jaishree has published both locally and internationally and has been an invited guest speaker and chaired many radiology and healthcare conferences. She also serves on the Executive Council of the World Federation of Paediatric Imaging (WFPI) and is an active member of the ESPR AI Taskforce as well as co-authored articles on AI imaging in children.

DR ZESHAN QURESHI

NHS PAEDIATRICIAN, TENDERTOUCH

CHT2023 Talk: Optimising sensory environment for sick preterm babies in NICUs

Zeshan Qureshi is a Paediatrician based in London, and is working on developing tactile devices to optimise the sensory environment for sick preterm babies. He graduated with Distinction from the University of Southampton. He co-edits the Oxford Textbook of Global Health of Women, Newborns, Children, and Adolescents, along with 14 other books, winning the BMA Young Author of the Year and the New Leader Award from the Association for the Study of Medical Education. He is a wellbeing advocate for doctors, and a TEDx speaker. He is currently a postgraduate student at the University of Cambridge study anti-racist medicine.

NATE MACABUAG

FOUNDER, KOALAA

CHT2023 Talk: Soft Prosthetics: A new approach to children’s prosthetics

Nate Macabuag is the founder of Koalaa, a startup on a mission to address the three main issues faced by the global limb difference community – access, affordability and comfort. 

It was while studying engineering at Imperial College London that Nate came up with the idea for a totally different type of prosthetic design, one driven by user need and inspired by a collaboration with quadruple amputee Alex Lewis.

Unlike traditional prosthetics, Koalaa’s are made from fabric which is breathable. This means they are light, comfy and suitable for even very young children and can be sent around the world for a fraction of the cost, further aiding accessibility.

Interchangeable tools can be attached, depending on the task the user would like to do, with skipping, yoga, riding a bike, holding a pen and playing the guitar, all being popular uses.

Alongside this, users benefit from peer-to-peer support and are linked with a trained limb buddy – an individual with personal experience of limb difference – who can provide prosthetics advice and guidance, every step of the way.

Koalaa prosthetics are now used by individuals across the world, with Nathan and Koalaa having won various UK and international awards.